BioCardia, Inc.
BCDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $58 | $477 | $1,352 | $1,015 |
| % Growth | -87.8% | -64.7% | 33.2% | – |
| Cost of Goods Sold | $4,387 | $7,726 | $8,834 | $640 |
| Gross Profit | -$4,329 | -$7,249 | -$7,482 | $375 |
| % Margin | -7,463.8% | -1,519.7% | -553.4% | 36.9% |
| R&D Expenses | $4,387 | $7,726 | $8,834 | $8,558 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $5,087 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$715 | -$3,331 | -$4,415 | -$640 |
| Operating Expenses | $3,672 | $4,395 | $4,419 | $13,005 |
| Operating Income | -$8,001 | -$11,644 | -$11,901 | -$12,630 |
| % Margin | -13,794.8% | -2,441.1% | -880.3% | -1,244.3% |
| Other Income/Exp. Net | $55 | $73 | -$6 | $7 |
| Pre-Tax Income | -$7,946 | -$11,571 | -$11,907 | -$12,623 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7,946 | -$11,571 | -$11,907 | -$12,621 |
| % Margin | -13,700% | -2,425.8% | -880.7% | -1,243.4% |
| EPS | -2.9 | -8.19 | -10.05 | -11.19 |
| % Growth | 64.6% | 18.5% | 10.2% | – |
| EPS Diluted | -2.9 | -8.19 | -10.05 | -11.19 |
| Weighted Avg Shares Out | 2,744 | 1,412 | 1,181 | 1,128 |
| Weighted Avg Shares Out Dil | 2,744 | 1,412 | 1,181 | 1,128 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $9 |
| Interest Expense | $0 | $0 | $6 | $0 |
| Depreciation & Amortization | $67 | $84 | $82 | $60 |
| EBITDA | -$7,934 | -$11,560 | -$11,819 | -$12,570 |
| % Margin | -13,679.3% | -2,423.5% | -874.2% | -1,238.4% |